These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24397198)

  • 1. Use of intravenous immunoglobulin in neonates with haemolytic disease and immune thrombocytopenia.
    Marković-Sovtić G; Janković B; Rakonjac Z; Martić J; Pejić K
    Vojnosanit Pregl; 2013 Nov; 70(11):1029-33. PubMed ID: 24397198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of intravenous immunoglobulin in the management of haemolytic disease of the newborn.
    Walsh SA; Yao N; El-Khuffash A; Twomey A; Molloy EJ
    Ir Med J; 2008 Feb; 101(2):46-8. PubMed ID: 18450249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn.
    Gottstein R; Cooke RW
    Arch Dis Child Fetal Neonatal Ed; 2003 Jan; 88(1):F6-10. PubMed ID: 12496219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome and management in neonatal thrombocytopenia due to maternal idiopathic thrombocytopenic purpura.
    van der Lugt NM; van Kampen A; Walther FJ; Brand A; Lopriore E
    Vox Sang; 2013 Oct; 105(3):236-43. PubMed ID: 23782272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early intravenous immunoglobin (two-dose regimen) in the management of severe Rh hemolytic disease of newborn--a prospective randomized controlled trial.
    Elalfy MS; Elbarbary NS; Abaza HW
    Eur J Pediatr; 2011 Apr; 170(4):461-7. PubMed ID: 20924607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose intravenous immunoglobulin therapy for rhesus haemolytic disease.
    Dağoğlu T; Ovali F; Samanci N; Bengisu E
    J Int Med Res; 1995; 23(4):264-71. PubMed ID: 7589769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulin therapy in neonatal immune hemolytic jaundice.
    Ergaz Z; Arad I
    J Perinat Med; 1993; 21(3):183-7. PubMed ID: 8229608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immunoglobulin in ABO and Rh hemolytic diseases of newborn.
    Nasseri F; Mamouri GA; Babaei H
    Saudi Med J; 2006 Dec; 27(12):1827-30. PubMed ID: 17143357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of immunomodulation in the treatment of profound thrombocytopenia after adult cardiac surgery.
    Rankin JS; Stratton CW
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):808-13; discussion 813-5. PubMed ID: 24239233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic disease of the newborn.
    Lieberman L; Lopriore E; Baker JM; Bercovitz RS; Christensen RD; Crighton G; Delaney M; Goel R; Hendrickson JE; Keir A; Landry D; La Rocca U; Lemyre B; Maier RF; Muniz-Diaz E; Nahirniak S; New HV; Pavenski K; Dos Santos MCP; Ramsey G; Shehata N;
    Br J Haematol; 2022 Jul; 198(1):183-195. PubMed ID: 35415922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The changing face of haemolytic disease of the newborn.
    Roberts IA
    Early Hum Dev; 2008 Aug; 84(8):515-23. PubMed ID: 18621490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulin in hemolytic disease of the newborn: A moving target in time.
    Vardar G; Okan MA; Karadag N; Topcuoglu S; Ozalkaya E; Karatepe HO; Karatekin G
    Niger J Clin Pract; 2022 Aug; 25(8):1262-1268. PubMed ID: 35975373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Meta analysis of the effect of immunoglobulin infusion on neonatal isoimmune hemolytic disease caused by blood group incompatibility].
    Li ZH; Wang J; Chen C
    Zhonghua Er Ke Za Zhi; 2010 Sep; 48(9):656-60. PubMed ID: 21092522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of the use of intravenous human immunoglobulin in Brazilian newborns with rhesus hemolytic disease: a randomized double-blind trial.
    Santos MC; Sá C; Gomes SC; Camacho LA; Moreira ME
    Transfusion; 2013 Apr; 53(4):777-82. PubMed ID: 22882285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulin in isoimmune haemolytic disease of newborn: an updated systematic review and meta-analysis.
    Louis D; More K; Oberoi S; Shah PS
    Arch Dis Child Fetal Neonatal Ed; 2014 Jul; 99(4):F325-31. PubMed ID: 24514437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose intravenous immunoglobulin therapy in neonatal immune haemolytic jaundice.
    Alpay F
    Acta Paediatr; 2000 Mar; 89(3):371-2. PubMed ID: 10772295
    [No Abstract]   [Full Text] [Related]  

  • 17. Single versus multiple dose intravenous immunoglobulin in combination with LED phototherapy in the treatment of ABO hemolytic disease in neonates.
    Demirel G; Akar M; Celik IH; Erdeve O; Uras N; Oguz SS; Dilmen U
    Int J Hematol; 2011 Jun; 93(6):700-703. PubMed ID: 21617887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemolytic disease of the newborn caused by rhesus isoimmunization (anti-c).
    Felc Z
    East Mediterr Health J; 2001 Nov; 7(6):1065-9. PubMed ID: 15332750
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravenous immunoglobulin in neonates with rhesus hemolytic disease: a randomized controlled trial.
    Smits-Wintjens VE; Walther FJ; Rath ME; Lindenburg IT; te Pas AB; Kramer CM; Oepkes D; Brand A; Lopriore E
    Pediatrics; 2011 Apr; 127(4):680-6. PubMed ID: 21422084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin infusion for isoimmune haemolytic jaundice in neonates.
    Alcock GS; Liley H
    Cochrane Database Syst Rev; 2002; (3):CD003313. PubMed ID: 12137687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.